1 ZhangZ X, RomanG C, HongZ, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai [J]. Lancet, 2005, 365(9459): 595-597. 2 MüllerB, AssmusJ, HerlofsonK, et al. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease [J]. Parkinsonism Relat Disord, 2013, 19(11): 1027-1032. 3 QinZ, ZhangL, SunF, et al. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort [J]. Clin Neurol Neurosurg, 2009, 111(9): 733-737. 4 ReijndersJ S, EhrtU, WeberW E, et al. A systematic review of prevalence studies of depression in Parkinson's disease [J]. Mov Disord, 2008, 23(2): 183-189, quiz 313. 5 ZhuoC, XueR, LuoL, et al. Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis [J]. Medicine (Baltimore), 2017, 96(22): e6698. 6 AarslandD, PåhlhagenS, BallardC G, et al. Depression in Parkinson disease-epidemiology, mechanisms and management [J]. Nat Rev Neurol, 2011, 8(1): 35-47. 7 Moraga-AmaroR, GonzalezH, PachecoR, et al. Dopamine receptor D3 deficiency results in chronic depression and anxiety [J]. Behav Brain Res, 2014, 274: 186-193. 8 ChangT T, ChenS L, ChangY H, et al. The DRD3 Ser9Gly polymorphism predicted metabolic change in drug-naive patients with bipolar II disorder [J]. Medicine (Baltimore), 2016, 95(24): e3488. 9 TeeS, TangP, LohH. Genetic association analysis of dopamine DRD3 Ser9Gly polymorphism and schizophrenia in Malay population [J]. Iran J Public Health, 2011, 40(2): 6-10. 10 GodlewskaB R, Olajossy-HilkesbergerL, LimonJ, et al. Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients [J]. Psychiatry Res, 2010, 177(1-2): 266-267. 11 KimB, ChoiE Y, KimC Y, et al. Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting [J]. Hum Psychopharmacol, 2008, 23(1): 61-67. 12 SpurlockG, WilliamsJ, McGuffinP, et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms [J]. Am J Med Genet, 1998, 81(1): 24-28. 13 MalhotraA K, GoldmanD, BuchananR W, et al. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response [J]. Mol Psychiatry, 1998, 3(1): 72-75. 14 PostumaR B, BergD, SternM, et al. MDS clinical diagnostic criteria for Parkinson's disease [J]. Mov Disord, 2015, 30(12): 1591-1601. 15 ChaudhuriK R, HealyD G, SchapiraA H. Non-motor symptoms of Parkinson's disease: diagnosis and management [J]. Lancet Neurol, 2006, 5(3): 235-245. 16 EvenC, WeintraubD. Is depression in Parkinson's disease (PD) a specific entity [J]. J Affect Disord, 2012, 139(2): 103-112. 17 LundstromK, TurpinM P. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system [J]. Biochem Biophys Res Commun, 1996, 225(3): 1068-1072. 18 PausS, GadowF, KautO, et al. Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism [J]. Parkinsonism Relat Disord, 2010, 16(6): 381-383. 19 XuS, LiuJ, YangX, et al. Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists [J]. J Neurol Sci, 2017, 372: 433-438. 20 LucotteG, LagardeJ P, FunalotB, et al. Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families [J]. Clin Genet, 2006, 69(5): 437-440. 21 王雪梅,冯涛,陈慧敏,等. 帕金森病抑郁与运动障碍的相关性分析[J]. 中国医药导报, 2017, 14(35): 4-7, 24. |